Diabetes Clinical Trials in Sacramento, CA

16 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Dietary Intervention to Improve Kidney Transplant Outcomes	N/A	University of California, Davis	<1 mi
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes	N/A	Medtronic Diabetes	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	<1 mi
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy	Phase 2	Boehringer Ingelheim	<1 mi
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes	N/A	University of California, Davis	<1 mi
Use of CGM in Kidney Transplant Recipients	N/A	University of California, Davis	<1 mi
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD	Phase 2	University of California, Davis	<1 mi
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease	Phase 3	Prokidney	<1 mi
Fenofibrate for Prevention of DR Worsening	Phase 3	Jaeb Center for Health Research	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin	Phase 3	Eli Lilly and Company	<1 mi
Metabolic Responses to Bariatric Surgery	—	University of California, Davis	<1 mi
Device Use Reimagined Through Education And Mentorship	N/A	University of California, San Francisco	14 mi
Metabolic and Bio-behavioral Effects of Following Recommendations in the Dietary Guidelines for Americans	N/A	USDA, Western Human Nutrition Research Center	14 mi
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide	Phase 3	Novo Nordisk A/S	24 mi
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)	Phase 3	Viking Therapeutics, Inc.	24 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis	Phase 2/3	CSL Behring	31 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.